CHARACTERIZATION OF RHESUS MACAQUE B LYMPHOBLASTOID CELL LINES INFECTED WITH SIMIAN TYPE D RETROVIRUS NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


CHARACTERIZATION OF RHESUS MACAQUE B LYMPHOBLASTOID CELL LINES INFECTED WITH SIMIAN TYPE D RETROVIRUS

Diss Abstr Int [B]; 52(5):2492 1991. Unique Identifier : AIDSLINE ICDB/92679523
Van Kuyk RW; Univ. of California, Davis


Abstract: Simian AIDS (SAIDS) is a fatal immunosuppressive disease in rhesus macaques caused by a simian type D retrovirus designated SAIDS-associated retrovirus (SRV). This syndrome shows many clinical similarities to human AIDS. To investigate the cellular basis of immune dysfunction in SRV infection, we studied the interactions of SRV serotype 1 (SRV-1) with rhesus macaque B lymphoblastoid cell lines (B-LCL). In addition, uninfected and SRV-1-infected B-LCL were used to determine the presence of virus-specific cytotoxic cells in PBMC obtained from SRV-1-infected macaques. Procedures were optimized for establishing B-LCL by immortalization of macaque B lymphocytes with rhesus Epstein-Barr virus (EBV). Phenotypic characterization of the B-LCL showed expression of B-cell surface markers and secretion of immunoglobulins of the IgG or IgM isotypes. In addition, the B-LCL release EBV which transform rhesus macaque B cells. Cultures of B-LCL were productively infected in vitro with SRV-1. Several B cell lines infected with SRV-1 showed downregulation of MHC class II antigen expression, whereas levels of MHC class I antigen remained unchanged. Infection of B-LCL with SRV-1 did not change the level of secreted immunoglobulins. Rhesus EBV was also used to obtain B-LCL from macaques infected with SRV-1; these cell lines were found to release infectious SRV-1. Cytopathic effects were not observed in macaque peripheral blood mononuclear cells (PBMC) or B-LCL infected with SRV-1. However, SRV-1 had immunosuppressive properties because the virus inhibited mitogen-induced proliferation in macaque PBMC. In addition, infection of PBMC with SRV-1 reduced natural killer activity. To study cell-mediated immune responses in infected rhesus macaques, uninfected and SRV-1-infected B-LCL were used as targets for cytotoxic PBMC obtained from viremic and nonviremic monkeys. Chromium release assays showed that viremic monkeys had cytotoxic activity against SRV-1-infected B-LCL but not against uninfected B-LCL. Thus, investigations on the interactions of SRV-1 with B cells will be useful for elucidating mechanisms involved in the immunopathogenesis of primate retroviruses. In addition, SRV-1 infection of B cell lines is a useful system for analyzing antiviral immune responses in infected macaques. (Full text available from University Microfilms International, Ann Arbor, MI, as Order No. AAD91-25117).
Keywords: Animal Antigens, Surface/ANALYSIS B-Lymphocytes/IMMUNOLOGY/*MICROBIOLOGY Cell Line Immunoglobulins/ANALYSIS Killer Cells, Natural/IMMUNOLOGY Macaca mulatta Retroviruses Type D, Simian/*IMMUNOLOGY Simian Acquired Immunodeficiency Syndrome/*IMMUNOLOGY THESISKWDanimalantigens,surface/analysisb-lymphocytes/immunology/KWDmicrobiologycelllineimmunoglobulins/analysiskillercells,natural/immunologymacacamulattaretrovirusestyped,simian/KWDimmunologysimianacquiredimmunodeficiencysyndrome/KWDimmunologythesis
920630
M9261018

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .